FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025781423> ?p ?o ?g. }

• W2025781423 endingPage "862" @default.
• W2025781423 startingPage "853" @default.
• W2025781423 abstract "BackgroundHomocysteine is an independent risk factor for atherosclerosis. The objective of this study was to investigate whether ginkgolide A (GA), a major constituent of Ginkgo biloba, could block homocysteine-induced endothelial dysfunction in porcine coronary arteries.MethodsPorcine coronary artery rings were assigned to six treatment groups: control; homocysteine (50 μmol/L); low-dose (50 μmol/L) or high-dose (100 μmol/L) GA; and homocysteine plus low-dose or high-dose GA. After 24 hours’ incubation, the rings were analyzed for vasomotor function in response to a thromboxane A2 analogue (U46619), bradykinin, and sodium nitroprusside. Endothelial nitric oxide synthase (eNOS) was studied by using real-time polymerase chain reaction and immunohistochemistry analysis. Superoxide anion production was assessed by chemoluminescence analysis.ResultsEndothelium-dependent relaxation (bradykinin) was significantly reduced in ring segments treated with homocysteine as compared with the control (P < .05). When homocysteine was combined with either low-dose or high-dose GA, endothelium-dependent relaxation was markedly recovered. There was no significant difference in maximal contraction (U46619) or endothelium-independent relaxation (sodium nitroprusside) among all groups. In addition, superoxide anion production was increased by 113% in the homocysteine-treated group, whereas there was no statistically significant difference between the control and GA/homocysteine groups. Furthermore, eNOS messenger RNA and protein levels were substantially reduced in the homocysteine-treated group (P < .05), but not in the GA/homocysteine combined groups.ConclusionsHomocysteine significantly impairs endothelium-dependent vasorelaxation through oxidative stress and downregulation of eNOS in porcine coronary arteries. GA effectively prevents homocysteine-induced endothelial dysfunction and molecular changes in porcine coronary arteries. This study underscores the potential clinical benefits and applications of GA in controlling homocysteine-associated vascular injury and cardiovascular disease. Homocysteine is an independent risk factor for atherosclerosis. The objective of this study was to investigate whether ginkgolide A (GA), a major constituent of Ginkgo biloba, could block homocysteine-induced endothelial dysfunction in porcine coronary arteries. Porcine coronary artery rings were assigned to six treatment groups: control; homocysteine (50 μmol/L); low-dose (50 μmol/L) or high-dose (100 μmol/L) GA; and homocysteine plus low-dose or high-dose GA. After 24 hours’ incubation, the rings were analyzed for vasomotor function in response to a thromboxane A2 analogue (U46619), bradykinin, and sodium nitroprusside. Endothelial nitric oxide synthase (eNOS) was studied by using real-time polymerase chain reaction and immunohistochemistry analysis. Superoxide anion production was assessed by chemoluminescence analysis. Endothelium-dependent relaxation (bradykinin) was significantly reduced in ring segments treated with homocysteine as compared with the control (P < .05). When homocysteine was combined with either low-dose or high-dose GA, endothelium-dependent relaxation was markedly recovered. There was no significant difference in maximal contraction (U46619) or endothelium-independent relaxation (sodium nitroprusside) among all groups. In addition, superoxide anion production was increased by 113% in the homocysteine-treated group, whereas there was no statistically significant difference between the control and GA/homocysteine groups. Furthermore, eNOS messenger RNA and protein levels were substantially reduced in the homocysteine-treated group (P < .05), but not in the GA/homocysteine combined groups. Homocysteine significantly impairs endothelium-dependent vasorelaxation through oxidative stress and downregulation of eNOS in porcine coronary arteries. GA effectively prevents homocysteine-induced endothelial dysfunction and molecular changes in porcine coronary arteries. This study underscores the potential clinical benefits and applications of GA in controlling homocysteine-associated vascular injury and cardiovascular disease." @default.
• W2025781423 created "2016-06-24" @default.
• W2025781423 creator A5020414704 @default.
• W2025781423 creator A5021814150 @default.
• W2025781423 creator A5038846608 @default.
• W2025781423 creator A5058198565 @default.
• W2025781423 creator A5076355638 @default.
• W2025781423 creator A5077723524 @default.
• W2025781423 creator A5088870041 @default.
• W2025781423 date "2006-10-01" @default.
• W2025781423 modified "2023-09-23" @default.
• W2025781423 title "Ginkgolide A attenuates homocysteine-induced endothelial dysfunction in porcine coronary arteries" @default.
• W2025781423 cites W1524490894 @default.
• W2025781423 cites W1964962284 @default.
• W2025781423 cites W1966292733 @default.
• W2025781423 cites W1972200288 @default.
• W2025781423 cites W1972914472 @default.
• W2025781423 cites W1997226677 @default.
• W2025781423 cites W1999328244 @default.
• W2025781423 cites W2023921247 @default.
• W2025781423 cites W2026143432 @default.
• W2025781423 cites W2042438285 @default.
• W2025781423 cites W2051386839 @default.
• W2025781423 cites W2081104218 @default.
• W2025781423 cites W2082365859 @default.
• W2025781423 cites W2098787238 @default.
• W2025781423 cites W2106169918 @default.
• W2025781423 cites W2131999937 @default.
• W2025781423 cites W2160189772 @default.
• W2025781423 cites W2163374884 @default.
• W2025781423 cites W2317172136 @default.
• W2025781423 cites W2323783182 @default.
• W2025781423 doi "https://doi.org/10.1016/j.jvs.2006.06.012" @default.
• W2025781423 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17012008" @default.
• W2025781423 hasPublicationYear "2006" @default.
• W2025781423 type Work @default.
• W2025781423 sameAs 2025781423 @default.
• W2025781423 citedByCount "27" @default.
• W2025781423 countsByYear W20257814232012 @default.
• W2025781423 countsByYear W20257814232014 @default.
• W2025781423 countsByYear W20257814232015 @default.
• W2025781423 countsByYear W20257814232017 @default.
• W2025781423 countsByYear W20257814232018 @default.
• W2025781423 countsByYear W20257814232020 @default.
• W2025781423 countsByYear W20257814232021 @default.
• W2025781423 countsByYear W20257814232022 @default.
• W2025781423 countsByYear W20257814232023 @default.
• W2025781423 crossrefType "journal-article" @default.
• W2025781423 hasAuthorship W2025781423A5020414704 @default.
• W2025781423 hasAuthorship W2025781423A5021814150 @default.
• W2025781423 hasAuthorship W2025781423A5038846608 @default.
• W2025781423 hasAuthorship W2025781423A5058198565 @default.
• W2025781423 hasAuthorship W2025781423A5076355638 @default.
• W2025781423 hasAuthorship W2025781423A5077723524 @default.
• W2025781423 hasAuthorship W2025781423A5088870041 @default.
• W2025781423 hasBestOaLocation W20257814231 @default.
• W2025781423 hasConcept C120770815 @default.
• W2025781423 hasConcept C126322002 @default.
• W2025781423 hasConcept C134018914 @default.
• W2025781423 hasConcept C170493617 @default.
• W2025781423 hasConcept C181199279 @default.
• W2025781423 hasConcept C185592680 @default.
• W2025781423 hasConcept C2776992346 @default.
• W2025781423 hasConcept C2777090595 @default.
• W2025781423 hasConcept C2777622882 @default.
• W2025781423 hasConcept C2778326061 @default.
• W2025781423 hasConcept C2779591629 @default.
• W2025781423 hasConcept C2779610285 @default.
• W2025781423 hasConcept C2780795997 @default.
• W2025781423 hasConcept C2780972559 @default.
• W2025781423 hasConcept C519581460 @default.
• W2025781423 hasConcept C55493867 @default.
• W2025781423 hasConcept C71924100 @default.
• W2025781423 hasConceptScore W2025781423C120770815 @default.
• W2025781423 hasConceptScore W2025781423C126322002 @default.
• W2025781423 hasConceptScore W2025781423C134018914 @default.
• W2025781423 hasConceptScore W2025781423C170493617 @default.
• W2025781423 hasConceptScore W2025781423C181199279 @default.
• W2025781423 hasConceptScore W2025781423C185592680 @default.
• W2025781423 hasConceptScore W2025781423C2776992346 @default.
• W2025781423 hasConceptScore W2025781423C2777090595 @default.
• W2025781423 hasConceptScore W2025781423C2777622882 @default.
• W2025781423 hasConceptScore W2025781423C2778326061 @default.
• W2025781423 hasConceptScore W2025781423C2779591629 @default.
• W2025781423 hasConceptScore W2025781423C2779610285 @default.
• W2025781423 hasConceptScore W2025781423C2780795997 @default.
• W2025781423 hasConceptScore W2025781423C2780972559 @default.
• W2025781423 hasConceptScore W2025781423C519581460 @default.
• W2025781423 hasConceptScore W2025781423C55493867 @default.
• W2025781423 hasConceptScore W2025781423C71924100 @default.
• W2025781423 hasIssue "4" @default.
• W2025781423 hasLocation W20257814231 @default.
• W2025781423 hasLocation W20257814232 @default.
• W2025781423 hasOpenAccess W2025781423 @default.
• W2025781423 hasPrimaryLocation W20257814231 @default.
• W2025781423 hasRelatedWork W2025781423 @default.
• W2025781423 hasRelatedWork W2048014021 @default.
• W2025781423 hasRelatedWork W2099366831 @default.

• next